Trademark: 79227875
Word
LIAISON MDX
Status
Registered
Status Code
700
Status Date
Tuesday, January 22, 2019
Serial Number
79227875
Registration Number
5658530
Registration Date
Tuesday, January 22, 2019
Mark Type
4000
Filing Date
Friday, July 28, 2017
Published for Opposition
Tuesday, November 6, 2018

Trademark Owner History
DIASORIN S.P.A. - Original Registrant

Classifications
9 Scientific apparatus and instruments, namely, molecular biological and immunological testing systems, namely, microarray scanners, DNA and protein chips, kits for multiplex polymerase chain reaction (PCR) tests consisting primarily of optical and electronic apparatus for analyzing biological or biochemical samples, namely, electrophoresis apparatus, nucleic acid and protein sequencing apparatus, and polymerase chain reaction (PCR) thermal cyclers, including associated hardware and software therefor and also containing devices for removing, marking, applying and identifying biological or biochemical samples, pipettes, or cannulae; diagnostic testing apparatus for scientific and research testing of biological or biochemical samples, namely, electrophoresis apparatus, nucleic acid and protein sequencing apparatus, and polymerase chain reaction (PCR) thermal cyclers; computer systems and software for collecting, storing, analysing and reporting biological information, and for sample tracking and managing projects, laboratory workflows and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes; software for electronic medical and diagnostic apparatus; software, namely, databanks and computer programs containing algorithms for helping to make medical decisions or carry out research, for diagnostic and therapeutic applications; Computer hardware for medical and diagnostic tasks; devices for generating images for detecting, quantifying and linking biological or chemical molecules; laboratory instruments, namely, genome sequencers; devices for generating images, namely, fluorimeters used to register fluorescence signals and produce data
5 Diagnostic preparations for medical purposes; diagnostic materials in the nature of medical diagnostic reagents and assays for extraction, testing and analysis of bodily fluids, namely, extraction of viral nucleic acid, bacterial nucleic acid, stool DNA, blood DNA, and RNA, and for the extraction and isolation of blood cells; preparations for use in medical diagnostic tests; chemical preparations for testing blood for medical purposes; chemical preparations for testing blood for veterinary purposes; in vitro diagnostic preparations for medical purposes; in vitro diagnostic preparations for veterinary purposes; chemicals for medical use for testing DNA; nucleic acid sequences for medical and veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reactants for medical diagnosis; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic substances for medical use; diagnostic substances for veterinary use; antiserums for diagnostic purposes; chemical test reagents for medical use; chemical test reagents for veterinary use; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; diagnostic chemical reagents for medical use; diagnostic chemical reagents for veterinary use; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents for pharmaceutical use; test strips for measuring blood glucose levels; medical diagnostic test strips; chemical diagnostic reagents for medical use for extracting, testing and analyzing body fluids, nucleic acids, DNA, RNA; chemical diagnostic reagents for medical use for extracting, isolating, testing and analyzing body fluids
10 Test kits for clinical medical use comprising test tubes, test plates and indicator diagrams for evaluating test results; apparatus for carrying out medical diagnoses, namely, fluorescence diagnostic apparatus and instruments used for the purpose of identifying infectious diseases and the severity thereof; diagnostic imaging apparatus for medical use; diagnostic lasers for medical use; medical and diagnostic devices, apparatus and equipment for molecular analysis; scanners for medical diagnosis; spectrum analyzers for use in medical diagnosis; Ultrasonic medical diagnostic apparatus being sources of ultrasonic fields for use in medical diagnosis; Magnetic apparatus being sources of magnetic fields for use in medical diagnosis; Electromagnetic medical diagnostic imaging apparatus being sources of electromagnetic fields for use in medical diagnosis; optical instruments for medical diagnostics; containers for disposal of medical instruments, namely, medical samples, syringes and plungers; Medical sampling vials of plastic or other materials for containing medical samples; Medical preparation vials of plastic or other materials for preparation of medical samples; diagnostic testing instruments for medical purposes, namely, electrical laboratory diagnostic instruments for the analysis of nucleic acids and proteins for medical use; diagnostic kits consisting primarily of electronic instruments for medical diagnosis and analysis of body fluids, tissues, biomolecules, DNA, antibodies, proteins, molecular material or cellular material; scientific apparatus for diagnostic testing of biological samples medical use; medical specimen cups
"MDX"

Trademark Events
Jan 22, 2024
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jun 1, 2019
Final Decision Transaction Processed By Ib
May 9, 2019
Final Disposition Notice Sent To Ib
May 9, 2019
Final Disposition Processed
Apr 22, 2019
Final Disposition Notice Created, To Be Sent To Ib
Feb 15, 2019
Teas Change Of Correspondence Received
Jan 22, 2019
Registered-Principal Register
Nov 6, 2018
Official Gazette Publication Confirmation E-Mailed
Nov 6, 2018
Published For Opposition
Nov 2, 2018
Notification Processed By Ib
Oct 17, 2018
Notification Of Possible Opposition Sent To Ib
Oct 17, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 17, 2018
Notification Of Notice Of Publication E-Mailed
Sep 28, 2018
Law Office Publication Review Completed
Sep 28, 2018
Assigned To Lie
Sep 18, 2018
Approved For Pub - Principal Register
Sep 18, 2018
Examiner's Amendment Entered
Sep 18, 2018
Notification Of Examiners Amendment E-Mailed
Sep 18, 2018
Examiners Amendment E-Mailed
Sep 18, 2018
Examiners Amendment -Written
Sep 5, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 5, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 6, 2018
Refusal Processed By Ib
Mar 19, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Mar 19, 2018
Refusal Processed By Mpu
Mar 13, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Mar 12, 2018
Non-Final Action Written
Mar 9, 2018
Application Filing Receipt Mailed
Mar 5, 2018
Assigned To Examiner
Mar 5, 2018
New Application Office Supplied Data Entered
Mar 1, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24